Sale will include all Emerald’s operations across Washington, US, the UK and the Netherlands
Specialty chemicals giant Lanxess has bought Emerald Kalama Chemical from its majority owner, private equity firm American Securities.
The sale, which is expected to complete in the second half of 2021, will include all of Emerald’s operations in its home state of Washington (US), the UK and the Netherlands.
The aforementioned facilities are used to manufacture consumer-friendly preservatives, nature-identical aroma chemicals, low-VOC coalescents and non-phthalate plasticisers and modifiers.
Emerald Kalama Chemical was formed in 2006 from the divesture of several businesses from Lubrizol. It was acquired by American Securities in 2014 and following this acquisition grew in Europe with the purchase of Innospec Widnes in the UK, in 2015.
“Emerald has grown at a rapid pace and we have continuously invested in expanding our capabilities,” commented Edward Gotch, CEO and Board member of Emerald.
“Lanxess has a sterling reputation within our industry as a global supplier, with a foundation built on exceptional service, responsible manufacturing and growth year-over-year.
“This is a fantastic development for Emerald, as Lanxess will be able to capitalise on existing successes and position our businesses to continue growing synergistically.”